Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don’t Change a Thing

by Camilla S. Graham, Susanna Naggie, David P. Holland et al.
Clin Infect Dis. (2017) 64 (1): 92-99

8 pp. 318 kB

Hepatitis C virus (HCV) direct-acting antivirals has renewed discussions as to whether these therapies could be used to prevent infection. The authors review transmission of HCV in the healthcare setting and provide an argument against post-exposure prophylaxis based on a simple cost analysis.

(Visited 16 times, 1 visits today)
This entry was posted in Essential Medicines, General, Human Resources, Other Infectious Diseases. Bookmark the permalink.